Recent studies have shown that the lactating mammary gland is able to utilize plasma-derived dipeptides for milk protein synthesis. However, it was not clear whether the peptides were hydrolysed followed by uptake of the constituent amino acids or were taken up intact. In view of this, we have designed experiments to investigate (a) whether the lactating rat mammary gland is capable of transporting hydrolysis-resistant dipeptides and (b) whether or not mammary cells are able to hydrolyse peptides, including glutathione, extracellularly. The uptake of the hydrolysis-resistant dipeptides D-
Introduction
Free amino acids are the major form in which amino-N is taken up by lactating mammary tissue. Accordingly, transport systems for neutral [1^4] , anionic [5, 6] and cationic amino acids [7, 8] have been identi¢ed in mammary tissue from a variety of species. A number of studies, however, have shown that the uptake of some essential amino acids, i.e. those which cannot be synthesized within the gland, is insu¤cient to account for their output in milk protein [9, 10] . In the goat, for example, it is apparent that the uptake of L-phenylalanine and Lhistidine falls short of the gland's requirements for milk protein production [11] and it has been suggested that the utilization of circulating peptides, as a source of amino acids for mammary protein synthesis, may account for the shortfall [12] . It appears that the mouse mammary gland is also capable of utilizing peptides as peptide-bound methionine can be used as a source of methionine for the synthesis of secreted proteins [13] . However, the mechanism by which the mammary gland utilizes peptides is not clear but may involve (a) extracellular hydrolysis followed by uptake of the constituent free amino acids, (b) intact peptide transport followed by intracellular hydrolysis to free amino acids, or (c) a combination of both hydrolysis and transport of peptides.
Using the rat as a model, the present study was designed to examine the mechanism by which the lactating mammary gland utilizes peptides for milk protein synthesis. The ¢rst step in the investigation was to measure the transport of hydrolysis-resistant peptides by the lactating rat mammary gland. Thus, we have examined the transport of dipeptides which have a D-isomer amino acid at the N terminus: this con¢guration confers resistance to hydrolysis [14] . Secondly, we have sought evidence for the extracellular hydrolysis of peptides followed by uptake of the free amino acids. To do this we have exploited the characteristics of a high-a¤nity, Na -dependent anionic amino acid transporter which has been shown to be present in the basolateral aspect of the rat mammary epithelium [5, 6] . It is apparent that the mammary tissue high a¤nity anionic amino acid transporter, in common with that expressed in neuronal cells [15] , is capable of operating as an exchanger as well as a cotransport system [6] ; L-glutamate, Laspartate and D-aspartate are able to trans-accelerate D-aspartate e¥ux (a poorly metabolized substrate of the transporter) from rat mammary tissue. We have examined the e¡ect of anionic dipeptides on the ef£ux of D-aspartate from mammary tissue. The rationale is that if mammary tissue is able to hydrolyse the peptides extracellularly (but not if the peptide remains intact) then the liberated anionic amino acid should subsequently trans-stimulate D-aspartate e¥ux from mammary tissue via the high-a¤nity anionic amino acid carrier.
Methods and materials

Animals
Lactating Wistar rats suckling between eight and ten pups and between 9 and 15 days of lactation were used in this study. The rats were fed on standard rat chow (Special Diet Services, Cambridge) and allowed free access to water. The animals were housed at constant temperature of 17³C and under conditions of 12 h light-dark cycles.
Measurement of dipeptide and amino acid uptake
by the perfused mammary gland
Mammary tissue was perfused according to the method described in detail by Clegg and Calvert [16] . Anaesthesia was induced and maintained throughout the experiment by an intraperitoneal injection of sodium pentobarbitone (40 mg/kg of body weight). Abdominal/inguinal mammary tissue was perfused via the super¢cial epigastric vessels. The perfusates contained (mM) 118 NaCl, 4 KCl, 2 CaCl 2 , 1 NaH 2 PO 4 , 1 MgSO 4 , 25 NaHCO 3 and 10 glucose and were gassed to pH 7.4 with 95% O 2 /5% CO 2 . In addition, all perfusates were supplemented with bovine serum albumin (5%). H]Gln) by the perfused rat mammary gland was measured using the rapid, paired-tracer dilution technique originally described by Yudilevich et al. [17] as modi¢ed by Millar et al. [5] . A mixture containing a radiolabelled dipeptide or amino acid and [ 14 C]sucrose was injected close arterially (approx. 60 Wl in 6 2 s) and 20 venous out£ow samples were collected at 6 s intervals. Venous out£ow samples (200 Wl) were mixed with 200 Wl of trichloroacetic acid and centrifuged at 13 000Ug for 2 min. Two hundred microlitres of the resultant supernatants were prepared for counting by adding 7 ml of Ultimagold liquid scintillation cocktail. The fractional uptake (U) of the dipeptides and amino acids for each collection period was calculated according to Eq. 1:
where R t is the ratio of radiolabelled dipeptide (or amino acid)/radiolabelled sucrose in the venous out£ow samples at time t and R i is the ratio of radiolabelled dipeptide (or amino acid)/radiolabelled sucrose in the injectate. 2 . Following the loading period, the mammary gland was perfused with solutions free of radioisotopes (see ¢gure legends for details of composition) and venous out£ow samples were collected at 2 min intervals. At the end of the perfusion period the gland was removed and homogenized. Samples of the homogenate were incubated in distilled water for at least 16 h in order to leach out the isotope. The amount of radioactivity associated with the homogenates was used to calculate the amount of isotope remaining in the tissue at the end of the perfusion. Venous out£ow and homogenate samples (0.75 ml) were mixed with 0.75 ml of 10% trichloroacetic acid and centrifuged at 13 000Ug for 3 min. One millilitre of the resulting supernatants was prepared for counting by adding 14 ml of Ultimagold liquid scintillation cocktail. The fractional e¥ux of radiolabelled D-aspartate e¥ux from the perfused mammary gland was calculated according to Eq. 2:
where vX represents the amount of radiolabelled Daspartate released from the tissue in the time interval vt and X t is the tissue D-[ 3 H]aspartate content at time t. The radioactivity associated with the tissue at any point of the time course was obtained by summing the counts left in the tissue at the end of the e¥ux time course with that of the 2 min samples in reverse order.
Preparation of mammary tissue explants
Mammary tissue explants were prepared by the method described by Shennan [18] . Rats were killed by cervical dislocation and the abdominal mammary glands were immediately removed and placed in an ice-cold bu¡er containing (mM) 135 NaCl, 5 KCl, 2 CaCl 2 , 1 MgSO 4 , 10 glucose and 20 Tris-MOPS, pH 7.4. The mammary tissue was ¢nely dissected to produce explants weighing between 4 and 8 mg.
Care was taken to remove as much connective tissue as possible during the preparation of the explants. The tissue explants were repeatedly washed with bu¡er prior to the start of the e¥ux experiments.
Measurement of D-aspartate e¥ux from mammary tissue explants
D-Aspartate e¥ux, using D-[ 3 H]aspartate as tracer, was assayed at 37³C according to the method described by Shennan [18] . Mammary tissue explants were loaded with radiolabelled D-aspartate by incubation at 20³C for 60 min in a bu¡er containing (mM) 135 NaCl, 5 KCl, 2 CaCl 2 , 1 MgSO 4 , 10 glucose and 20 Tris-MOPS, pH 7.4 plus 3^5 WCi/ml D-[ 3 H]aspartate. Following the loading incubation, the tissue explants were transferred through a series of tubes each containing 2 ml of radioactive-free solutions (see ¢gure legends for precise details of composition) at 2 min intervals. The radioactivity in these samples was measured. At the end of the e¥ux incubation, the tissue explant was placed in 4 ml of distilled water (for at least 16 h) in order to leach out the remaining isotope. The fractional e¥ux for each collection period was calculated according to Eq. 2.
Measurement of taurine e¥ux from mammary tissue explants
Isolated rat mammary tissue explants, prepared as described above, were loaded with [ 3 H]taurine by incubating for 60 min at 20³C in a medium containing (mM) 135 NaCl, 5 KCl, 2 CaCl 2 , 1 MgSO 4 , 10 glucose and 20 Tris-MOPS, pH 7.4 to which was added 1^3 WCi ml 31 of radiolabelled taurine. The e¥ux of radiolabelled taurine was assayed at 37³C as described for D-aspartate. 
Materials
Statistics
Di¡erences were assessed by Student's paired t-test and considered signi¢cant when P 6 0.05. 3 H]Glu clearance, which is via a high a¤nity anionic amino acid transport system, is similar to that reported by Millar et al. [5] . To test whether or not the small clearance of D- [ 3 H]Phe-L-Glu was via a high a¤nity peptide transport system we examined the e¡ect of adding excess unlabelled L-Leu-LAla to the injectate (at 50 mM). It is evident from low (Fig. 2) . It is evident from Fig. 2 
Results
The clearance of
All of the peptides, with the exception of L-Leu-L-Ala, contained either a glutamate or an aspartate residue. Table 1 shows the e¡ect of these peptides, added to the incubation medium to give a ¢nal concentration of 500 WM, on the fractional e¥ux of D-aspartate. Shown for comparison is the e¡ect of free L-glutamate and L-aspartate (both tested at 500 WM) on D-aspartate e¥ux. It is evident that L-Glu-L-Ala was the most e¡ective dipeptide tested. Indeed, L-Glu-L-Ala was 75% as e¡ective as free L-glutamate in trans-acceler- and Tris-MOPS, pH 7.4 followed by one of similar composition (for 20 min) except that it contained a dipeptide or an anionic amino acid (at 500 WM). The fractional e¥uxes ( þ S.E.M.) shown are those just prior to the addition of the peptide (3peptide) and those at the peak response (+peptide).`t' represents the time (min) taken to reach the peak response following the addition of the peptide or amino acid and`n' is the number of experiments performed with each peptide or amino acid. The L-Asp data are taken from Miller et al. [6] .
ating D-aspartate e¥ux with respect to both the size and latency of stimulation. Fig. 3 shows that L-Glu-L-Ala stimulated D-aspartate e¥ux from rat mammary tissue explants in a concentration-dependent manner. The next most potent peptides tested were L-Ala-L-Asp, L-Asp-L-Ala and L-Asp-Gly (Table 1) . On the other hand, Gly-L-Asp and Gly-L-Glu were relatively weak stimulators of D-aspartate e¥ux. In addition, the non-hydrolysable peptide D-Phe-L-Glu was without e¡ect on D-aspartate e¥ux. Similarly, LLeu-L-Ala, the only neutral dipeptide tested, had no signi¢cant e¡ect on D-aspartate e¥ux from mammary tissue explants (Table 1) . We wanted to rule out the possibility that the dipeptides were increasing D-aspartate e¥ux from mammary tissue explants as a consequence of cell lysis. Therefore, we examined the e¡ect of L-Glu-LAla on the fractional release of radiolabelled taurine. L-Glu-L-Ala, tested at a concentration of 500 WM, had no e¡ect on the fractional e¥ux of taurine (results not shown) con¢rming that the e¡ects of the stimulatory peptides on D-aspartate transport are speci¢c. (n = 4, P 6 0.05) by 500 WM L-Glu.
The e¡ect of glutathione on D-aspartate e¥ux from mammary tissue
The tripeptide glutathione (Q-glutamyl-cysteinylglycine), the most abundant oligopeptide in the body, is a potential source of L-glutamate for the lactating mammary gland [19] . Therefore, we tested the e¡ect of glutathione on the e¥ux of D-aspartate from rat mammary tissue explants and the perfused lactating rat mammary gland. Fig. 5 illustrates that glutathione at a concentration of 500 WM markedly stimulated D-aspartate e¥ux from mammary tissue explants; the tripeptide increased the fractional e¥ux (trough-to-peak) from 0.0080 þ 0.0009 min 31 to 0.0242 þ 0.0027 min 31 (n=8; P 6 0.001). We found that the e¡ect of glutathione on D-aspartate e¥ux was inhibited by acivicin (1 mM), an inhibitor of Qglutamyltranspeptidase in lactating rat mammary tissue [20] . In contrast, acivicin (1 mM) did not inhibit the e¡ect of 500 WM L-Glu on D-aspartate e¥ux from mammary tissue explants suggesting that the e¡ect of acivicin on Q-glutamyltranspeptidase activity is relatively speci¢c (results not shown). Glutathione (at 500 WM) also stimulated D-aspartate release from the perfused mammary gland; the fractional e¥ux was increased (trough-to-peak) from 0.0017 þ 0.0001 min 31 to 0.0046 þ 0.0004 min 31 (n = 3, P 6 0.05).
Discussion
Transport of non-hydrolysable peptides by the perfused mammary gland
The ¢rst step in the investigation demonstrated that the clearance of two hydrolysis-resistant dipeptides, namely D- [ 3 H]Phe-L-Glu and D-[ 3 H]Phe-L-Gln which are substrates of epithelial peptide transporters (e.g. see [21, 22] ), by the perfused lactating mammary gland was very low even under conditions designed to maximize uptake of the radiolabelled compounds. On the other hand, the clearance of two of the constituent amino acids (L-Glu and L-Gln) was high suggesting that the uptake of free amino acids by the lactating mammary gland is quantitatively more important than that of intact dipeptides.
The fact remains, however, that there was a small, albeit signi¢cant uptake of the non-hydrolysable peptides by the basolateral membranes of the lactating rat mammary epithelium. The question is what is the nature of the pathway responsible for this measurable uptake of the dipeptides? The clearance of both peptides was not signi¢cantly inhibited by excess unlabelled neutral dipeptide suggesting that the small clearances cannot be attributed to uptake via a high a¤nity peptide transport system such as PepT1 or PepT2 [23, 24] . These transporters, which are proton not sodium linked, are expressed in the apical membrane of certain epithelia (e.g. proximal tubule, small intestine); the processes subserving peptide transport across the basolateral membrane of these tissues, as in the mammary gland, remain unknown. In view of these ¢ndings it appears that dipeptide uptake by the lactating rat mammary gland is the result of transport via a low a¤nity pathway (see [25] ); experimentally this will be di¤cult to distinguish kinetically from di¡usion.
Extracellular hydrolysis of dipeptides by the mammary gland
The results from the second part of the study clearly show that the mammary gland is capable of hydrolysing dipeptides extracellularly. Thus, anionic dipeptides are capable of trans-stimulating D-aspartate e¥ux from lactating rat mammary tissue. According to the model depicted in Fig. 6 (using L- Glu-L-Ala as an example), we believe that the mammary gland rapidly hydrolyses the dipeptides followed by uptake of free anionic amino acids via the high a¤nity anionic amino acid transporter [5, 6] . It appears that the mammary gland has a large capacity to hydrolyse dipeptides. This is based on the ¢nding that L-Glu-L-Ala was 75% as e¡ective as free L-glutamate in stimulating D-aspartate e¥ux from tissue explants. Moreover, the results strongly suggest that the site of hydrolysis is extracellular; anionic amino acids must be at the trans aspect of the membrane in order to stimulate D-aspartate e¥ux via the anionic amino acid transporter. If the peptides were being hydrolysed intracellularly, D-aspartate e¥ux would have been inhibited as a consequence of competition between the liberated anionic amino acids and D-aspartate for a binding site at the internal face of the anionic amino acid transporter. Furthermore, the ¢nding that certain dipeptides were capable of increasing D-aspartate e¥ux from the perfused mammary gland suggests that the locus of hydrolysis is at the blood-facing (i.e. basolateral) aspect of the mammary epithelium. This is based on the reasonable assumption that the perfused gland provides a measure of transport across the blood-facing aspect of the mammary epithelium. It is possible that the peptides were also hydrolysed by endothelial cells. However, the ¢nding that anionic dipeptides stimulated D-aspartate e¥ux from mammary tissue explants, an experimental preparation in which the vast majority of the surface area exposed to the incubation medium is that of the secretory cells (and not the endothelium), suggests that the peptides are hydrolysed by the basolateral membranes of the acinar cells. Tissue utilization of peptides is not a new concept. There are many studies relating to the use of peptides in human parenteral nutrition which have shown that infused or injected peptides disappear rapidly from the circulation and, since they do not appear in urine, it has been inferred that the peptides are hydrolysed in vivo, with the constituent amino acids entering the free amino acid pool [26^28]. Indeed, direct incorporation into milk casein of leucine and phenylalanine derived from intravascularly infused Gly-L-[
13 C]Phe and Gly-L-[ 13 C]Leu has been demonstrated in goats [12] . In that study, however, it was not clear whether peptides were hydrolysed systemically or by the mammary gland itself. The present study is the ¢rst to show direct mammary tissue hydrolysis of dipeptides and transport of the constituent amino acids. Furthermore, given the experimental conditions, blood or plasma hydrolysis of the peptides can be ruled out.
Interestingly, not all of the anionic peptides stimulated D-aspartate e¥ux to the same extent. In particular, D-Phe-L-Glu had no e¡ect on D-aspartate e¥ux supporting the claim that dipeptides containing a Disomer amino acid at the N terminus resist hydrolysis. In addition, those peptides which contained glycine at the N terminus were weak at trans-stimulating D-aspartate release. This is consistent with previous ¢ndings that peptides with glycine at the N terminus are more resistant to hydrolysis [26] .
Metabolism of glutathione by the lactating rat mammary gland
The results show that glutathione is capable of stimulating D-aspartate e¥ux from the mammary gland. This suggests that the mammary gland is able to hydrolyse glutathione and the glutamate residue so released is able to trans-stimulate D-aspartate via the high a¤nity anionic amino acid transport system. It has been previously shown that rat and bovine mammary tissue expresses relatively high levels of Q-glutamyltranspeptidase, an enzyme which can catalyse the release of glutamate from glutathione [29] . The observation that the e¡ect of glutathione on D-aspartate e¥ux from mammary tissue was inhibited by acivicin is consistent with the notion that Q-glutamyltranspeptidase was responsible for hydrolysing glutathione. Glutathione may be an important physiological source of glutamate (and of cysteine) for the mammary gland. In this connection Pocius et al. [20] presented evidence for an arterio-venous glutathione concentration di¡erence across the mammary gland.
The study reported here does not shed light on the handling of peptides at the apical face of the mammary epithelium. It does, however, indicate that, in addition to nutrition, there are questions of relevance to the mechanisms of drug delivery to the suckling neonate (e.g. protease inhibitors) which may be explored using the experimental protocols described here.
